Literature DB >> 24985403

Haploidentical T-cell alpha beta receptor and CD19-depleted stem cell transplant for Wiskott-Aldrich syndrome.

Gaurav Kharya1, Zohreh Nademi2, T Ronan Leahy1, Janice Dunn3, Dawn Barge4, Ansgar Schulz5, Andrew Cant2, Andrew Gennery2, Mary Slatter6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24985403     DOI： 10.1016/j.jaci.2014.04.041

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

1.  TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation.

Authors:  R Bhattacharyya; A M Tan; M Y Chan; S S Jamuar; R Foo; P Iyer
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

2.  Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.

Authors:  P Kreetapirom; S Hongeng; W Manuyakorn; U Anurathapan; S Pakakasama; N Sirachainan; B S Andersson
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

Review 3.  Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.

Authors:  Akira Nishimura; Satoshi Miyamoto; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2022-06-08       Impact factor: 2.490

4.  Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.

Authors:  Nirali N Shah; Alexandra F Freeman; Helen Su; Kristen Cole; Mark Parta; Niki M Moutsopoulos; Safa Baris; Elif Karakoc-Aydiner; Thomas E Hughes; Heidi H Kong; Steve M Holland; Dennis D Hickstein
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-10       Impact factor: 5.742

5.  Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.

Authors:  Emma C Morris; Thomas Fox; Ronjon Chakraverty; Rita Tendeiro; Katie Snell; Christine Rivat; Sarah Grace; Kimberly Gilmour; Sarita Workman; Karen Buckland; Katie Butler; Ronnie Chee; Alan D Salama; Hazem Ibrahim; Havinder Hara; Cecile Duret; Fulvio Mavilio; Frances Male; Frederick D Bushman; Anne Galy; Siobhan O Burns; H Bobby Gaspar; Adrian J Thrasher
Journal:  Blood       Date:  2017-07-17       Impact factor: 22.113

Review 6.  Disease Presentation, Treatment Options, and Outcomes for Myeloid Immunodeficiencies.

Authors:  Elizabeth M Kang
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-05       Impact factor: 4.806

Review 7.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

Review 8.  T-Cell-Replete Versus ex vivo T-Cell-Depleted Haploidentical Haematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukaemia and Other Haematological Malignancies.

Authors:  Katharina Kleinschmidt; Meng Lv; Asaf Yanir; Julia Palma; Peter Lang; Matthias Eyrich
Journal:  Front Pediatr       Date:  2021-12-24       Impact factor: 3.418

Review 9.  Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life.

Authors:  Kanwaldeep K Mallhi; Aleksandra Petrovic; Hans D Ochs
Journal:  J Blood Med       Date:  2021-06-11

10.  Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.

Authors:  Wolfgang A Bethge; Matthias Eyrich; Stephan Mielke; Roland Meisel; Dietger Niederwieser; Paul G Schlegel; Ansgar Schulz; Johann Greil; Donald Bunjes; Arne Brecht; Jurgen Kuball; Michael Schumm; Vladan Vucinic; Markus Wiesneth; Halvard Bonig; Kasper Westinga; Stefanie Biedermann; Silke Holtkamp; Sandra Karitzky; Michaela Malchow; Christiane Siewert; Rupert Handgretinger; Peter Lang
Journal:  Bone Marrow Transplant       Date:  2021-12-24       Impact factor: 5.174
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.